Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Alpha-9 Oncology has raised $175m in a Series C funding round to advance its pipeline of radiopharmaceuticals. Credit: eamesBot via Shutterstock. Alpha-9 Oncology is the

Share this article Harpoon’s T-cell are engineered antibodies that redirect T cells to attack cancer cells. Image credit: Shutterstock/Meletios Verras. MSD has entered a definitive